Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical EGCG for radiation-induced dermatitis in breast cancer
NCT02580279Phase 2Unknown
- Sponsor
- Shandong Cancer Hospital
- Start
- Dec 2014
- Primary completion
- Aug 2019
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of epigallocatechin gallate in radiation-induced dermatitis (RID), sponsored by Shandong Cancer Hospital. Status: unknown.
02
Drugs
epigallocatechin gallate
03
Conditions
radiation-induced dermatitis (RID)
Beyond the preview
Go deeper on NCT02580279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580279.